Free Trial

Promising Healthcare Stocks To Research - October 14th

Johnson & Johnson logo with Medical background

Key Points

  • Johnson & Johnson, UnitedHealth Group, and Hims & Hers Health are highlighted as key healthcare stocks to monitor, based on significant trading volume.
  • UnitedHealth Group operates diversified health care services across multiple segments, including consumer health plans, Medicaid, and health benefits for various employers.
  • Hims & Hers Health provides a telehealth platform that connects consumers with healthcare professionals for a variety of health services, emphasizing the growth of remote healthcare access.
  • MarketBeat previews the top five stocks to own by November 1st.

Johnson & Johnson, UnitedHealth Group, and Hims & Hers Health are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of companies that operate in the healthcare sector — including pharmaceuticals, biotechnology, medical device makers, hospitals and clinics, health insurers, and contract research and services — that are bought and sold on public markets. For investors, they offer exposure to demand for medical products and services and can behave defensively in downturns, but carry sector‑specific risks such as regulatory approval, patent expirations, and reimbursement or policy changes. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Read Our Latest Research Report on JNJ

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Read Our Latest Research Report on HIMS

Further Reading

Should You Invest $1,000 in Johnson & Johnson Right Now?

Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.